Atlas Trials

A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Clinical trial NCT04252586 · TERMINATED

Trial details

NCT number
NCT04252586
Sponsor
Jazz Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Rett SyndromeRTT
Start date
2020-02-28
Primary completion
2021-06-09
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.